5 Hot Biotech Stocks With Fresh Buy Ratings
Analysts initiate coverage with Buy ratings on Sensei (SNSE), Septerna (SEPN), Kazia (KZIA), NervGen (NGEN), and Sutro (STRO).
Already have an account? Sign in.
Analysts initiate coverage with Buy ratings on Sensei (SNSE), Septerna (SEPN), Kazia (KZIA), NervGen (NGEN), and Sutro (STRO).
Anthropic may go public in November at about $2 trillion after delaying an October window to show Q3 results following OpenAI’s Astra launch.
Meritage, operator of 314 Wendy’s restaurants, filed for bankruptcy protection and is seeking financing to keep stores open.
The $110B Warner deal offers growth but faces execution risk, cable decline, and delays.